
Novo Holdings Participates in €90 Million Series A Financing Round for Orbis Medicines to Support Development of Oral Macrocycle Drugs
Published on January 6, 2025
and Company, Cormorant, the Export and Investment Fund of Denmark , alongside existing investors Novo Holdings and Forbion. Morten Graugaard
Other news
